DK619987A - Galenisk formulering - Google Patents

Galenisk formulering

Info

Publication number
DK619987A
DK619987A DK619987A DK619987A DK619987A DK 619987 A DK619987 A DK 619987A DK 619987 A DK619987 A DK 619987A DK 619987 A DK619987 A DK 619987A DK 619987 A DK619987 A DK 619987A
Authority
DK
Denmark
Prior art keywords
galenic formulation
galenic
formulation
Prior art date
Application number
DK619987A
Other languages
English (en)
Other versions
DK619987D0 (da
Inventor
Kimon Ventouras
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of DK619987D0 publication Critical patent/DK619987D0/da
Publication of DK619987A publication Critical patent/DK619987A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK619987A 1986-11-27 1987-11-26 Galenisk formulering DK619987A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868628359A GB8628359D0 (en) 1986-11-27 1986-11-27 Galenical formulation

Publications (2)

Publication Number Publication Date
DK619987D0 DK619987D0 (da) 1987-11-26
DK619987A true DK619987A (da) 1988-05-28

Family

ID=10608029

Family Applications (1)

Application Number Title Priority Date Filing Date
DK619987A DK619987A (da) 1986-11-27 1987-11-26 Galenisk formulering

Country Status (13)

Country Link
US (1) US4886669A (da)
EP (1) EP0273005A1 (da)
JP (1) JPS63211224A (da)
AU (1) AU603624B2 (da)
DK (1) DK619987A (da)
FI (1) FI875209A7 (da)
GB (1) GB8628359D0 (da)
HU (1) HU201867B (da)
IE (1) IE873213L (da)
IL (1) IL84569A (da)
NZ (1) NZ222701A (da)
PT (1) PT86212B (da)
ZA (1) ZA878882B (da)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
US5466469A (en) * 1988-06-28 1995-11-14 Cibus Pharmaceutical, Inc. Granular drug delivery system
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US4970078A (en) * 1989-05-25 1990-11-13 Aqualon Company Crosslinked carboxymethyguar tablet disintegrant
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
IT1264020B (it) * 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
NO941358L (no) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
NZ287277A (en) * 1994-05-13 1998-05-27 Smithkline Beecham Corp Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach
FR2722408B1 (fr) * 1994-07-15 1996-10-04 Vacher Dominique Nouveau procede de realisation de formes pharmaceutiques seches a delitement quasiment instantane etles formes pharmaceutiques ainsi realisees
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
DE19734538C1 (de) * 1997-07-30 1998-12-24 Jenapharm Gmbh Bioadhäsive Tablette
IN186245B (da) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
ATE238774T1 (de) * 1997-10-09 2003-05-15 Dexcel Pharma Technologies Ltd Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
DK0991415T3 (da) * 1997-12-22 2003-06-16 Schering Corp Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
JP2004500361A (ja) 1999-12-20 2004-01-08 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 固形のケラチン繊維用染料
CN1196463C (zh) 1999-12-20 2005-04-13 汉高两合股份公司 用于角蛋白纤维的固体染色剂
CN100387225C (zh) * 1999-12-20 2008-05-14 汉高两合股份公司 稠化体系的制片方法
DE19961910A1 (de) 1999-12-20 2001-06-21 Henkel Kgaa Färbemittel
WO2002072033A2 (en) 2001-03-13 2002-09-19 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
WO2002100381A1 (en) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003086353A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
EA200500213A1 (ru) * 2002-07-16 2005-08-25 Рэнбакси Лабораториз Лимитед Диспергируемые таблетки для орального назначения
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20070014850A1 (en) * 2002-08-02 2007-01-18 Ramalingam Manikandan Process for the preparation of dispersible tablets of cephalexin
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CN102552917A (zh) * 2003-08-13 2012-07-11 比奥孔有限公司 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
AP2006003585A0 (en) 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
WO2005044236A1 (en) * 2003-10-27 2005-05-19 Control Delivery Systems, Inc. Suspension delivery system for the sustained and controlled local release of pharmaceuticals
EP1753398B1 (en) * 2004-06-10 2018-09-19 Glatt Air Techniques, Inc. Controlled release matrix pharmaceutical dosage formulation
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP1906937B1 (en) 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR100753480B1 (ko) * 2006-01-27 2007-08-31 씨제이 주식회사 잘토프로펜 함유 서방성 정제 및 그 제조방법
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
JP4361597B2 (ja) * 2006-11-13 2009-11-11 伊那食品工業株式会社 崩壊剤、並びにそれが含まれた錠剤及び顆粒
WO2008104996A2 (en) * 2007-02-28 2008-09-04 Jubilant Organosys Limited Water dispersible pharmaceutical formulation and process for preparing the same
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20110027374A1 (en) * 2008-12-16 2011-02-03 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
CN108601957B (zh) 2015-12-23 2021-12-10 高露洁-棕榄公司 储存稳定的固体过一硫酸盐组合物
MX388205B (es) 2016-08-11 2025-03-19 Colgate Palmolive Co Composición de polvo dental de peroximonosulfato para las manchas resistentes.
US11259551B2 (en) 2016-09-09 2022-03-01 International Agriculture Group, LLC Natural cocoa alternative and methods of producing same
WO2018049242A1 (en) 2016-09-09 2018-03-15 International Agriculture Group, LLC Yogurt product from high starch fruits
US20220233415A1 (en) 2021-01-25 2022-07-28 Colgate-Palmolive Company Solid Oral Care Compositions
CA3206909A1 (en) 2021-02-19 2022-08-25 Cajetan DOGO-ISONAGIE Peroxymonosulfate whitening strips
EP4200026B1 (en) 2021-04-23 2026-01-14 Colgate-Palmolive Company Solid oral care compositions
JP7782842B2 (ja) * 2022-06-02 2025-12-09 株式会社パウレック 速崩壊性圧縮成形物の製造方法および速崩壊性圧縮成形物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH536632A (de) * 1968-10-21 1973-05-15 Boehringer Sohn Ingelheim Trägermasse für Arzneimitteltabletten und Verfahren zu deren Herstellung
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
NL7311319A (da) * 1972-09-01 1974-03-05
JPS5438167B2 (da) * 1974-04-27 1979-11-19
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
EP0181966A1 (en) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Compression-coated dispersible tablets
ES8801121A1 (es) * 1985-02-19 1988-01-01 Key Pharma Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4681759A (en) * 1985-05-08 1987-07-21 Ortho Pharmaceutical Corporation Rioprostil-PVP complex
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation

Also Published As

Publication number Publication date
FI875209A0 (fi) 1987-11-25
PT86212B (pt) 1990-11-07
HU201867B (en) 1991-01-28
EP0273005A1 (en) 1988-06-29
ZA878882B (en) 1989-07-26
JPS63211224A (ja) 1988-09-02
IE873213L (en) 1988-05-27
PT86212A (en) 1987-12-01
US4886669A (en) 1989-12-12
AU8182387A (en) 1988-06-02
AU603624B2 (en) 1990-11-22
HUT45193A (en) 1988-06-28
NZ222701A (en) 1990-06-26
IL84569A (en) 1991-06-10
FI875209L (fi) 1988-05-28
IL84569A0 (en) 1988-04-29
DK619987D0 (da) 1987-11-26
FI875209A7 (fi) 1988-05-28
GB8628359D0 (en) 1986-12-31

Similar Documents

Publication Publication Date Title
DK619987A (da) Galenisk formulering
DK0394026T3 (da) Formulering
NO1998020I1 (no) Raltitrexed
FI870169L (fi) Stabiliserat tokoferol i fri-flytande partikelform
DK224687D0 (da) Aktive forbindelser
FR2592763B1 (fr) Composition antiseptique
BR8600462A (pt) Formulacao herbicida
FI88825C (fi) Aktivt pansar
DK10087A (da) Praeparat
DK244488A (da) Efterskummende praeparat
DK255787D0 (da) Praeparat
MX5577A (es) Formulacion farmaceutica
DK142487D0 (da) Farmaceutiske midler
DK574187A (da) Analgetiske praeparater
IT1216814B (it) Composizioni farmaceutiche
DK8188D0 (da) Veterinaert praeparat
DK674187A (da) Aktive forbindelser
DK30788D0 (da) Co-vaccinationspraeparat
DK574087A (da) Anti-hypertensivt praeparat
AR241147A1 (es) "disposotivos taquimetricos"
SE8601596D0 (sv) Pallbock
DK493887D0 (da) Buccal formulering
LV5815A4 (lv) Benzhidriltiometana atvasinajumus saturosas terapeitiskas kompozicijas
TR23120A (tr) Ensektisid olarak kullanilabilen n'-suebstituee edilmis-n-asil-n'-hidrazinler
IT8719708A0 (it) Formulazione farmaceutica.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment